Peptipedia
BioregulatorNot FDA ApprovedClinical Trials

Epithalon

Also known as Epitalon, Epithalone, AGAG

A tetrapeptide studied for its effects on telomerase activation and potential anti-aging properties.

Investigational - Primarily Russian research
CompareFind Vendors

Regulatory Pathway

Preclinical
Phase I
Phase II
Phase III
Phase IV
Approved

Dosing Protocol

Typical Dose

5-10 mg daily for 10-20 days

Frequency

Once daily in cycles

Duration

10-20 day cycles (repeated 1-2x per year)

Community-reported dosing. Individual results vary. Not a medical recommendation.
Typical community protocol: 5-10 mg daily for 10-20 days via Subcutaneous or intramuscular injection, Once daily in cycles. Dose range: 5-10 mg daily. Duration: 10-20 day cycles (repeated 1-2x per year).

Timing & Administration

Administer via Subcutaneous or intramuscular injection. Frequency: Once daily in cycles.

Mechanism of Action

Stimulates telomerase production, potentially slowing or reversing telomere shortening. May also regulate melatonin production by the pineal gland and influence gene expression related to aging.

Research Summary

Evidence level: clinical trials. Clinical status: Investigational - Primarily Russian research.

Side Effects & Safety

Important Warnings

  • Long-term safety not established
Injection site reactions
mild headache
sleep disturbances
immunogenicity risk

References

No references available.

Related Peptides

Browse all →
ThymalinBioregulator

A thymic peptide complex utilized in Russia for immune enhancement and longevity support, developed through Professor Khavinson's bioregulator peptide research.

View profile
PinealonBioregulator

A synthetic tripeptide bioregulator targeting brain tissue, designed to support cognitive function and neuroprotection as part of Khavinson's peptide research.

View profile
VilonBioregulator

A synthetic dipeptide bioregulator targeting thymic function. Part of Khavinson's peptide bioregulator research for immune and anti-aging effects.

View profile